The invention relates to bacterial antibiotic resistance and, in particular,
to compositions and methods for overcoming bacterial antibiotic resistance. The
invention provides novel -lactamase inhibitors, which are structurally unrelated
to the natural product and semi-synthetic -lactamase inhibitors presently
available, and which do not require a -lactam pharmacophore. The invention
also provides pharmaceutical compositions and methods for inhibiting bacterial growth.
